Silexion Therapeutics Corp. (SLXN)
0.2146
-0.02
(-8.64%)
USD |
NASDAQ |
Oct 09, 16:00
0.204
-0.01
(-4.94%)
After-Hours: 20:00
Silexion Therapeutics EPS Diluted (Quarterly) : -5.166 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.166 |
| March 31, 2026 | -8.460 |
| December 31, 2025 | -14.11 |
| September 30, 2025 | -28.80 |
| June 30, 2025 | -43.19 |
| March 31, 2025 | -0.2559 |
| December 31, 2024 | -141.75 |
| September 30, 2024 | -18.31 |
| June 30, 2024 | -1977.97 |
| March 31, 2024 | -1910.48 |
| December 31, 2023 | -2668.86 |
| September 30, 2023 | 0.1341 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.0274 |
| March 31, 2023 | 0.0289 |
| December 31, 2022 | 0.0333 |
| September 30, 2022 | 0.0197 |
| June 30, 2022 | 0.0258 |
| March 31, 2022 | -0.1489 |
| December 31, 2021 | -0.0163 |
| September 30, 2021 | -0.1356 |
| June 30, 2021 | -0.1162 |
| March 31, 2021 | -0.0592 |
| December 31, 2020 | -0.0132 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioLineRx Ltd. | -0.6957 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 0.1605 |
| Can-Fite BioPharma Ltd. | -- |
| Eocene Ltd. | -2.860 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.551M |
| Total Expenses (Quarterly) | 3.551M |
| Enterprise Value | -0.5948M |
| Earnings Yield | -26.35K% |
| Normalized Earnings Yield | -26480.99 |